21 – 30 of 96
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2017
-
Mark
Alterations of striatal indirect pathway neurons precede motor deficits in two mouse models of Huntington's disease
(
- Contribution to journal › Article
- 2016
-
Mark
Translational approach for gene therapy in epilepsy: Model system and unilateral overexpression of neuropeptide Y and Y2 receptors.
(
- Contribution to journal › Article
-
Mark
Platelet-derived growth factor-BB has neurorestorative effects and modulates the pericyte response in a partial 6-hydroxydopamine lesion mouse model of Parkinson's disease
(
- Contribution to journal › Article
-
Mark
Validation of an improved scale for rating L-DOPA-induced dyskinesia in the mouse and effects of specific dopamine receptor antagonists
(
- Contribution to journal › Article
-
Mark
Dissociation of metabolic and hemodynamic levodopa responses in the 6-hydroxydopamine rat model
(
- Contribution to journal › Article
-
Mark
Dramatic differences in susceptibility to L-DOPA-induced dyskinesia between mice that are aged before or after a nigrostriatal dopamine lesion
(
- Contribution to journal › Article
- 2015
-
Mark
Characterisation of immune cell function in fragment and full-length Huntington's disease mouse models.
(
- Contribution to journal › Article
-
Mark
A cell culture model for monitoring α-synuclein cell-to-cell transfer.
(
- Contribution to journal › Article
-
Mark
Cystamine/cysteamine rescues the dopaminergic system and shows neurorestorative properties in an animal model of Parkinson's disease.
(
- Contribution to journal › Article
-
Mark
Inflammation without neuronal death triggers striatal neurogenesis comparable to stroke.
(
- Contribution to journal › Article